glp-1 and substance use disorder drugs linked to lower addiction rates in large study of veterans | Science GLP-1 Receptor Agonist Use Linked

The continued prevalence of Ozempic and Wegovy in treatment regimens for diabetes and obesity makes it crucial to further investigate these side effects for ongoing patient care

Many older people may still not be able to afford an extra $600 a year for another prescription, especially as they grapple with rising healthcare costs

The doctors reported on the remarkably high rate of favorable responses we have seen from ad hoc use of such drugs in the cases presented here of MCAS and stated that overall clinical benefit was found in 89% of patients

DOI: 10.1002/ctm2.1232 [Google Scholar] Pattison LA, Rickman RH, Hilton H, Dannawi M, Wijesinghe SN, Ladds G, et al